Literature DB >> 16504700

Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population?

A Hałoń1, D Patrzałek, J Rabczyński.   

Abstract

AIM: The aim of this research was a histopathological assessment of cadaveric donor liver steatosis including: the degree (percent of involved hepatocytes) and type size of vacuoles showing fatty change by various histologic techniques.
MATERIALS AND METHODS: The study included 70 donor livers. Hematoxylin-eosin and Sudan III staining methods were used for the examination. The degree of steatosis was assessed according to the Dixon scale with the type of fatty degeneration classified into three steatotic patterns.
RESULTS: Steatosis was observed in 36/70 donor livers (51.4%) including those from 23 male (64%) and 13 female (36%) patients. The mean age of the steatotic donors was 53.7 years in contrast to the nonsteatotic donors of 45.3 years. Mild steatosis was identified in five of all sections (7.1%); mild focal and moderate zonal steatosis in 10 (14.3%), and severe, panlobular steatosis in 11 (15.3%). Fatty liver was observed as the only microscopic feature in nine cases (13%), in combination with cholestasis in 2 (2.8%); with inflammation in 5 (7%); and together with inflammation, fibrosis, and cholestasis in 20 (29%). Three types of steatotic pattern were shown: (1) small-droplet lipid vacuolization (microsteatosis) in 7/36 cases (19%); (2) large and small fat drops (macromicrosteatosis) in 8/36 (22%); and (3) typical macrosteatosis in 21/36 (59%) cases.
CONCLUSIONS: Moderate to severe steatosis is a quite frequent finding in donor livers. Donor livers with 1(0) or 2(0) steatosis as the only pathological feature can be successfully used in orthotopic liver transplantation.

Entities:  

Mesh:

Year:  2006        PMID: 16504700     DOI: 10.1016/j.transproceed.2005.11.088

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

Review 1.  Bioengineering in organ transplantation: targeting the liver.

Authors:  K Fukumitsu; H Yagi; A Soto-Gutierrez
Journal:  Transplant Proc       Date:  2011 Jul-Aug       Impact factor: 1.066

2.  Hepatic steatosis is not always a contraindication for cadaveric liver transplantation.

Authors:  Jan P Deroose; Geert Kazemier; Pieter Zondervan; Jan N M Ijzermans; Herold J Metselaar; Ian P J Alwayn
Journal:  HPB (Oxford)       Date:  2011-04-07       Impact factor: 3.647

3.  Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.

Authors:  Yuichiro Eguchi; Hideyuki Hyogo; Masafumi Ono; Toshihiko Mizuta; Naofumi Ono; Kazuma Fujimoto; Kazuaki Chayama; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2012-02-11       Impact factor: 7.527

4.  Microsteatosis in Livers From Donation After Circulatory Death Donors Is Associated With Inferior Outcomes Following Liver Transplantation.

Authors:  Natalie M Bath; Glen Leverson; David P Al-Adra; Anthony M D'Alessandro; Joshua D Mezrich; David P Foley
Journal:  Liver Transpl       Date:  2020-09       Impact factor: 5.799

5.  Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.

Authors:  Oren Shaked; Jack Demetris; Josh Levitsky; Sandy Feng; Bao-Li Loza; Jeff Punch; Jorge Reyes; Goran Klintmalm; Whitney Jackson; Michele DesMarais; Peter Sayre; Abraham Shaked; K Rajender Reddy
Journal:  Transplantation       Date:  2022-01-01       Impact factor: 5.385

6.  The role of molecular chaperonins in warm ischemia and reperfusion injury in the steatotic liver: a proteomic study.

Authors:  Venkataswarup Tiriveedhi; Kendra D Conzen; Jane Liaw-Conlin; Gundumi Upadhya; James Malone; R Reid Townsend; Robnet Kerns; Jianluo Jia; Krista Csontos; Sabarinathan Ramachandran; Thallachallour Mohanakumar; Christopher D Anderson; William C Chapman
Journal:  BMC Biochem       Date:  2012-09-10       Impact factor: 4.059

7.  Higher thresholds for the utilization of steatotic allografts in liver transplantation: Analysis from a U.S. national database.

Authors:  Justin A Steggerda; Matthew B Bloom; Mazen Noureddin; Todd V Brennan; Tsuyoshi Todo; Nicholas N Nissen; Andrew S Klein; Irene K Kim
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.